Actuate brings in $21.7M for GSK-3beta inhibitor program BioWorld Online By John Harbison|2019-05-22T04:14:56-08:00May 20, 2019|Tech Coast Angels Portfolio Companies in the Press|Comments Off on Actuate brings in $21.7M for GSK-3beta inhibitor program Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts
